Authored By: Sarah
11 Jul 2024

 Vascular Grafts Market Size to grow by USD 1518.4 million between 2024-2028

According to a research report “ Vascular Grafts Market” by Product (Endovascular grafts, Bypass grafts, Hemodialysis grafts, Peripheral grafts) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 1518.4 million, at a CAGR of  7.08% during the forecast period. The vascular grafts market has witnessed significant advancements over the past decade, with the emergence of innovative surgical tools and techniques. Notably, off-pump coronary artery bypass (OPCAB) procedures have gained popularity among skilled surgeons, leading to reduced postoperative blood loss and transfusion requirements. This minimally invasive approach is particularly beneficial for high-risk patient groups, such as those with aortic atheroma, cirrhosis, or renal insufficiency. Furthermore, patient preferences for minimally invasive procedures and the desire to avoid anterior chest scars have fueled the adoption of alternative techniques, such as those that avoid sternotomy. Consequently, smaller incisions have become increasingly common in some surgical practices, addressing patient concerns and enhancing overall patient satisfaction.

Browse market data tables, figures, and in-depth TOC on “Vascular Grafts Market” by Product (Endovascular grafts, Bypass grafts, Hemodialysis grafts, Peripheral grafts) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Product, the Endovascular grafts segment is projected to dominate the market size in 2024

ai_market_segmentation_by

By Geography, North America  segment is expected to hold the largest market size for the year 2024

The vascular grafts market represents a significant business opportunity due to the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive surgical procedures. Vascular grafts are essential medical devices used in the replacement or bypass of damaged or diseased blood vessels. Market growth is driven by factors such as an aging population, rising healthcare expenditures, and technological advancements in graft materials and manufacturing processes. Companies in this sector can capitalize on these trends by offering innovative, high-quality, and cost-effective solutions to meet the evolving needs of healthcare providers and patients.

North America is forecasted to hold the largest market size by region in 2024

The vascular grafts market represents a significant business opportunity due to the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive surgical procedures. Vascular grafts are essential medical devices used to replace damaged or diseased blood vessels, and their market is expected to grow steadily due to advancements in biomaterials and surgical techniques. Companies in this sector focus on research and development to produce innovative and effective grafts, ensuring patient safety and optimal clinical outcomes.

The Vascular Grafts Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Artivion Inc.
  • Aruga Technologies
  • B.Braun SE
  • Becton Dickinson and Co.
  • Bentley InnoMed GmbH
  • BIOTRONIK SE and Co. KG
  • BIOVIC Sdn Bhd
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Endologix LLC
  • Getinge AB
  • Heart Medical Europe BV
  • InnAVasc Medical Inc.
  • Japan Lifeline Co. Ltd.
  • LeMaitre Vascular Inc.
  • Lombard Medical Ltd.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Terumo Corp.
  • Vascular Graft Solutions Ltd.
  • W. L. Gore and Associates Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The global vascular grafts market is expected to grow significantly due to the increasing prevalence of chronic diseases such as diabetes, heart attacks, and abdominal aneurysms. The market is driven by the rising healthcare expenditure, government funding, and the growing geriatric population. Minimally invasive procedures like MIDCAB (Minimally Intrusive Coronary Artery Bypass) have gained popularity, leading to an increase in demand for vascular grafts. Aortic cross clamp-free surgeries and constructive graft remodeling techniques are also contributing to market growth. However, challenges such as thrombosis and intimal hyperplasia remain significant obstacles. The COVID-19 pandemic has disrupted the healthcare system, leading to delays in surgical procedures. Raw materials used in vascular grafts include polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), and Dacron. Smoking and chronic diseases like hemodialysis and hemodialysis vascular access are major risk factors for the need for vascular grafts. Emerging economies are expected to offer significant growth opportunities due to their large patient populations and increasing healthcare spending. In conclusion, the vascular grafts market is expected to grow significantly due to the increasing prevalence of chronic diseases, rising healthcare expenditure, and the growing geriatric population. However, challenges such as thrombosis and intimal hyperplasia, as well as the impact of COVID-19 on surgical procedures, may affect market growth.

Market Research Overview

The global vascular grafts market is witnessing significant growth due to the increasing prevalence of vascular occlusion caused by cardiac aneurysms, peripheral vascular diseases, and other chronic conditions. Vascular grafts, including hybrid, synthetic (polyester, PTFE, and polyurethane), and biomaterial grafts, are used to bypass vascular obstacles caused by disease or surgical procedures such as cardiopulmonary bypass, aortic cross clamp, and minimally invasive procedures like MIDCAB. Cutting-edge grafts, such as constructive graft remodeling, are being developed to mitigate complications like thrombosis and intimal hyperplasia. The market is driven by healthcare expenditure, reimbursement schemes, and government funding. Factors like the aging population, rising prevalence of chronic diseases (diabetes, heart attacks), and Corona virus infections are further fueling market growth. Key players in the market include MDPI, W.L. Gore & Associates, Maquet Holding B.V., and Terumo Corporation. Raw materials like polyester, PTFE, and polyurethane are used in the production of vascular grafts. Applications include endovascular aneurysm repair, hemodialysis vascular access, and surgical procedures. Smoking and geriatric population are major risk factors for vascular diseases, leading to an increased demand for vascular grafts. Emerging economies, such as China and India, are expected to offer significant growth opportunities due to their large populations and increasing healthcare infrastructure.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio